New Stock News | Cino Medical (688108.SH) plans to list on the Hong Kong Stock Exchange. The China Securities Regulatory Commission requires further explanation on changes in share capital and shareholders.

According to the SmartFinance APP, on July 3, the China Securities Regulatory Commission issued the "Supplementary Materials Requirements for Overseas Issuance and Listing Recordation (June 29, 2026 - July 3, 2026)". The CSRC's International Department required 7 companies to provide supplementary materials. Among them, Sinocare Medical was required to provide detailed information on the company's establishment and changes in share capital and shareholders since its establishment, including but not limited to capital increases, share transfers, and related payment of consideration. According to the Hong Kong Stock Exchange disclosure on May 27, Sinocare Medical Technology Co., Ltd. submitted an application for listing on the Main Board of the Hong Kong Stock Exchange, with CMB International as the sole sponsor.